Wan Jovian, Park Hyun Jin, Choi Ho-Sung, Yi Kyu-Ho
Medical Research Inc., Wonju, Korea.
Department of Anatomy, Daegu Catholic University School of Medicine, Daegu, Korea.
J Cosmet Dermatol. 2025 Feb;24(2):e16700. doi: 10.1111/jocd.16700. Epub 2024 Dec 18.
The combination of hyaluronic acid (HA) fillers and polydioxanone (PDO) thread lifting is gaining popularity for mid-face rejuvenation, especially among the Asian population. Despite the common use of these techniques, there is a paucity of long-term studies assessing their combined efficacy and safety. This study aims to evaluate the efficacy and safety of combined HA filler and PDO thread treatment for mid-face rejuvenation over a 24-month period in a Korean population.
This prospective, blinded, single-center, open-label trial included 11 Korean subjects, aged 29-70 years, with mid-face volume loss graded 1-4 on the antero-medial cheek fullness scale. Participants were treated with crosslinked HA dermal fillers and PDO threads. Assessments were conducted using the Global Aesthetic Improvement Scale (GAIS), investigator-led clinical evaluations, and volumetric measurements using the Morpheus 3D system at baseline, 6, 12, and 24 months post-treatment.
Quantitative analysis revealed a significant reduction in mid-face width from an average baseline of 149.27-145.00 mm at 24 months (p < 0.00001). Similarly, lower-face width decreased from 130.36 to 117.27 mm at 24 months (p < 0.00001). The GAIS scores demonstrated high levels of subject satisfaction, with 9 out of 11 patients reporting consistent satisfaction or improvement over 24 months. Minimal adverse events were reported, and no serious complications occurred.
The combination of HA fillers and PDO threads was effective in achieving and maintaining long-term improvements in facial volume and contour. The Morpheus 3D system provided objective volumetric data, which supported the subjective improvements observed by patients and investigators. The study results highlight the benefits of ongoing neocollagenesis and tissue remodeling beyond the dissolution period of the materials.
The combination of HA filler injections and PDO thread lifting offers a promising and minimally invasive option for long-term mid-face rejuvenation with high patient satisfaction and a favorable safety profile. Further studies are warranted to confirm these findings across diverse populations and compare this approach with other aesthetic treatments.
透明质酸(HA)填充剂与聚对二氧环己酮(PDO)线雕相结合用于面部中部年轻化正越来越受欢迎,尤其是在亚洲人群中。尽管这些技术被广泛使用,但评估其联合疗效和安全性的长期研究却很少。本研究旨在评估在韩国人群中,联合使用HA填充剂和PDO线治疗面部中部年轻化24个月的疗效和安全性。
这项前瞻性、双盲、单中心、开放标签试验纳入了11名年龄在29至70岁之间的韩国受试者,其面部中部容量减少在面颊前内侧丰满度量表上分级为1至4级。参与者接受了交联HA真皮填充剂和PDO线治疗。在基线、治疗后6个月、12个月和24个月时,使用全球美学改善量表(GAIS)、研究者主导的临床评估以及使用Morpheus 3D系统进行容积测量。
定量分析显示,面部中部宽度从基线时的平均149.27毫米显著减少至24个月时的145.00毫米(p < 0.00001)。同样,下部面部宽度在24个月时从130.36毫米降至117.27毫米(p < 0.00001)。GAIS评分显示受试者满意度较高,11名患者中有9名报告在24个月内持续满意或有改善。报告的不良事件极少,未发生严重并发症。
HA填充剂和PDO线的联合使用有效地实现并维持了面部容量和轮廓的长期改善。Morpheus 3D系统提供了客观的容积数据,支持了患者和研究者观察到的主观改善。研究结果突出了在材料溶解期之后持续的新胶原形成和组织重塑的益处。
HA填充剂注射和PDO线雕相结合为长期面部中部年轻化提供了一种有前景的微创选择,患者满意度高且安全性良好。有必要进行进一步研究以在不同人群中证实这些发现,并将这种方法与其他美容治疗方法进行比较。